Posted inAntitrust Laws and Competition Issues Drugs (Pharmaceuticals) Humira (Drug) Intellectual Property Inventions and Patents Prices (Fares, Fees and Rates) Suits and Litigation (Civil)
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.